Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • Antifolate
    (1)
Filter
Search Result
Results for "

farletuzumab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
Farletuzumab
MORAb-003
T76720896723-44-7
Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-α (FRα), acting as a potent inhibitor of FRα and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.
  • $228
In Stock
Size
QTY
Farletuzumab ecteribulin
MORAb-202
T779082407465-18-1
Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate (ADC) targeting human folate receptor alpha (FRA). This ADC comprises the humanized Farletuzumab antibody linked to Mal-PEG2-Val-Cit-PAB-eribulin through reduced interchain disulfide bonds, with an agent-to-antibody ratio of 4.0, demonstrating potent antitumor activity against FRA-positive cells in vitro.
  • Inquiry Price
8-10 weeks
Size
QTY
Farletuzumab MMAE
T9901A-207
Farletuzumab-MMAE, an antibody-drug conjugate (ADC), combines an FRA-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in researching non-small cell lung cancer.
  • Inquiry Price
Size
QTY